1. Home
  2. MTZ vs BIO Comparison

MTZ vs BIO Comparison

Compare MTZ & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MasTec Inc.

MTZ

MasTec Inc.

N/A

Current Price

$323.44

Market Cap

22.9B

Sector

Industrials

ML Signal

N/A

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

N/A

Current Price

$271.80

Market Cap

7.1B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
MTZ
BIO
Founded
1929
1952
Country
United States
United States
Employees
N/A
7450
Industry
Water Sewer Pipeline Comm & Power Line Construction
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
22.9B
7.1B
IPO Year
2005
N/A

Fundamental Metrics

Financial Performance
Metric
MTZ
BIO
Price
$323.44
$271.80
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
19
4
Target Price
$285.78
$358.50
AVG Volume (30 Days)
951.1K
238.3K
Earning Date
04-30-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
146.12
N/A
EPS
5.07
N/A
Revenue
$14,299,171,000.00
N/A
Revenue This Year
$20.38
$2.74
Revenue Next Year
$10.02
$3.05
P/E Ratio
$59.28
$9.72
Revenue Growth
16.22
N/A
52 Week Low
$99.70
$211.43
52 Week High
$316.19
$343.12

Technical Indicators

Market Signals
Indicator
MTZ
BIO
Relative Strength Index (RSI) 65.92 48.13
Support Level $164.00 $266.71
Resistance Level N/A $289.61
Average True Range (ATR) 13.02 7.91
MACD 0.17 1.02
Stochastic Oscillator 96.28 42.97

Price Performance

Historical Comparison
MTZ
BIO

About MTZ MasTec Inc.

MasTec is a leading infrastructure construction company operating mainly in North America across a range of industries. Its primary activities include engineering, building, installing, maintaining, and upgrading communications, oil and gas, utility, renewable energy, and other infrastructure. MasTec reports its results under five segments: communications; clean energy and infrastructure; pipeline infrastructure; power delivery; and other.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: